or
forgot password

    • cancer clinical trials in durham, NC

    • Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Anaplastic Large-Cell Lymphoma
    Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Head and Neck Cancer, Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Regional Hematology Oncology Associates

    Trial Locations
    Regional Hematology Oncology Associates
    Regional Hematology Oncology Association
    Non Small Cell Lung Carcinoma
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer
    Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Cervical Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Regional Hamatology Oncology Associates
    Durham, North Carolina 27704
    Non-Small Cell Lung Cancer
    Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
    Morris Cancer Center - Duke University Medical Center, Adult Bone Marrow Transplant Clinic
    Durham, North Carolina 27705
    Hematologic Malignancies, Leukemia, Myelodysplastic Syndromes, Myeloid Metaplasia, Lymphoma
    Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
    Duke University
    Durham, North Carolina 27710
    Ovarian Neoplasms, Fallopian Tube Neoplasms, Genital Neoplasms, Female
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Cervical Cancer
    Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
    The Brain Tumor Center at Duke, Duke University Medical Center
    Durham, North Carolina 27710
    Malignant Glioma, Glioblastoma, Gliosarcoma
    BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
    Duke University Medical Center
    Durham, North Carolina 27710
    Lymphoma, Non-Hodgkin
    Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD)
    Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
    Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma
    Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
    Duke University Medical Center
    Durham, North Carolina 27710
    Impotence, Prostate Cancer
    Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
    Duke University/Division of Gynecologic Oncology
    Durham, North Carolina 27710-0001
    Ovarian Cancer
    Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.
    Duke University Medical Center
    Durham, North Carolina 27710
    Neoplasms
    Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Carcinoma, Non-Small-Cell Lung
    Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma
    Abraxis BioScience Inc.
    Durham, North Carolina 27703
    Melanoma, Metastases
    MRI Sarcoma Non Invasive Thermometry
    Duke Cancer Institute
    Durham, North Carolina 27710
    Sarcoma
    Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
    Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma Multiforme
    Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors
    Duke University Medical Center
    Durham, North Carolina 27710
    Neoplasms
    Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Non Small Cell Lung Cancer
    Lapatinib in Treating Young Patients With Recurrent or Refractory CNS Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Gestational Trophoblastic Tumor
    Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Recurrent Grades 1-3 Follicular Lymphoma, Follicular Lymphoma
    Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia
    FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
    Duke University Medical Center
    Durham, North Carolina 27710
    Lymphoma, Non-Hodgkin
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
    Duke University Medical Center
    Durham, North Carolina 27710
    Multiple Myeloma
    Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
    Duke University
    Durham, North Carolina 27710
    Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis
    AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
    Duke Univaersity Medical Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Tumor RNA Transfected Dendritic Cell Vaccines
    Durham VA Medical Center
    Durham, North Carolina 27705
    Prostate Cancer
    A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Duke University Medical Center
    Durham, North Carolina 27710
    Non-Small-Cell Lung Carcinoma
    Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia
    Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Leukemia, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Sarcoma
    Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
    The Brain Tumor Center at Duke, Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma Multiforme
    Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention
    Durham VA Medical Center HSR&D COE
    Durham, North Carolina 27705
    Colorectal Cancer
    Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
    Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
    Durham, North Carolina 27710
    Hemoglobinuria, Paroxysmal
    Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program
    Durham, North Carolina 27710
    Paroxysmal Hemoglobinuria, Nocturnal
    Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
    Duke University Health System, Division of Cell Therapy, Heme Malignancies Program
    Durham, North Carolina 27710
    Hemoglobinuria, Paroxysmal
    Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
    Duke University Medical Center
    Durham, North Carolina 27710
    Mycosis Fungoides, Sezary Syndrome
    Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    A Study to Evaluate PT-523 in Patients With Refractory Leukemia
    Duke University Medical Center
    Durham, North Carolina 27710
    Leukemia
    Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
    Duke University Medical Center
    Durham, North Carolina 27710
    Metastatic Breast Cancer
    Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
    Department of Radiation Oncology; Duke University Medical Center
    Durham, North Carolina 27710
    Head and Neck Cancer, Pharynx Cancer
    Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
    Duke University Medical Center
    Durham, North Carolina 27710
    Mycosis Fungoides
    An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
    A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Colorectal Cancer
    Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
    Duke University Medical Center Dept. of DUMC (3)
    Durham, North Carolina 27710
    Brain Metastasis, Non-small Cell Lung Cancer
    Maribavir for Prevention of CMV After Stem Cell Transplants
    Duke Medical Center
    Durham, North Carolina
    Cytomegalovirus Infection
    Testing Pharmacological Therapies for Pregnant Smokers
    Duke University Medical Center
    Durham, North Carolina 27710
    Smoking, Pregnancy
    Treatment for Acute Graft-Versus-Host Disease
    Duke University Medical Center (Peds)
    Durham, North Carolina 27705
    Graft vs Host Disease, Immune System Disorders
    Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
    Duke University Medical Center
    Durham, North Carolina 27710
    Tumor Lysis Syndrome, Cancer, Hyperuricemia
    Safety and Tolerability of Repeat Courses of IM Alefacept
    Duke University Medical Center
    Durham, North Carolina 27710
    Chronic Plaque Psoriasis
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    Duke University Hospital
    Durham, North Carolina 27710
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    Duke University Hospital
    Durham, North Carolina 27710
    Pain, Cancer, Sickle Cell Anemia, Severe Burns